Immo Pharma Pas
ActiveSummary
Immo Pharma Pas has been active since 1991 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €192,530 and a net result of -€14,718. Equity has been stable since 2019 (±1.9% per year). Its solvency ranks better than 90% of 487 sector peers (NACE 70, financial year 2026). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 26-03-1991 Normal situation
- Activity
- Business and other management consultancy NACE 70200
- Establishment unit
- 2.052.291.455 2460 Kasterlee, since 10-04-1991
- Financial year end
- 31 March
- Peppol
- Reachable since 04-12-2025
Board and ownership
- Bellens MarleenDirector · since 26-03-1991
- Van Der Staey WillyDirector · since 26-03-1991
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
- Gross margin
- -€868
- Loss
- €14,718
- ▲ 13.2%
- Equity
- €192,530
- ▼ 20.5%
- Total assets
- €204,009
- ▼ 16.0%
Score breakdownraises riskLoss of €14,718, the second in a row (financial year 2026)lowers riskLiquidity: current ratio 16.74, cash €157,493Size: total assets €204,009Equity €192,530 (94.4% of total assets)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 70, micro). It does better than 86% of them on solvency, 97% on liquidity, 11% on profitability and 22% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-03-2026.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 65 days before the deadline. In the sector (NACE 70), the median for financial year 2024 was 9 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
Key points
- Risk: 3 loss-making years in a rowloss in financial year 2026 -€14,718 View
- Caution: Lower net result than 89% of companies in head offices and management consultancysector median €44,501 · 487 companies -€14,718 View
- Positive: Filed on time since financial year 2019accounts within the deadline every year 8 years View
Recent changes
- · Gazette deed Amendment of the articlesGeneral meeting of 22-05-2026
- · Gazette deed Capital decrease of €37,250 to €62,000Capital from €99,250 to €62,000 · Resignation: VAN DER STAEY Sofie Maria Franciska (director) · “Beheer van apotheken; Managementactiviteiten van holdings : tussenkomen in het dagelijks bestuur…” (deed in Dutch)
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as Immo Pharma Pas: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €166,000 and €225,000, founded between 1990 and 1996.
| Company | Total assets | Gross margin |
|---|---|---|
| Immo Pharma Pas Kasterlee | €204,009 | -€868 |
| HELLEMANS Duffel | €190,917 | -€5,664 |
| IMMO HOF VAN LACHENEN Lier | €225,400 | €1,116 |
| ADVIESBUREAU LUIJTEN Ravels | €175,708 | -€3,052 |
| TER POEL Bornem | €169,636 | -€8,254 |
| VIKTOR G. Rumst | €165,908 | -€24,451 |
| HUVECON Zoersel | €206,278 | -€8,207 |
Key facts about Immo Pharma Pas
- What is the company number of Immo Pharma Pas?
- The company number of Immo Pharma Pas is 0443.688.490. The VAT number is the same number with BE in front: BE 0443.688.490.
- Where is Immo Pharma Pas based?
- The registered office is at Mezenstraat 2, 2460 Kasterlee.Company details
- What does Immo Pharma Pas do?
- According to the KBO register, the main activity is business and other management consultancy (NACE 70200).
- What is the legal form of Immo Pharma Pas?
- Immo Pharma Pas is a public limited company (NV).
- When was Immo Pharma Pas founded?
- Immo Pharma Pas was founded on 26-03-1991.
- Is Immo Pharma Pas still active?
- Yes, Immo Pharma Pas is an active enterprise in the KBO register.
- What is the turnover of Immo Pharma Pas?
- The annual accounts for financial year 2026 state no turnover. The abbreviated or micro format does not require it.Financials
- Is Immo Pharma Pas profitable?
- In financial year 2026, Immo Pharma Pas made a loss of €14,718.
- Where can I find the annual accounts of Immo Pharma Pas?
- Immo Pharma Pas filed 35 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
- When are the next annual accounts of Immo Pharma Pas due?
- Immo Pharma Pas must file the annual accounts for financial year 2027 by 31-10-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.